Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Health»Indian Doctor Gains Spotlight for Osteomyelitis Cure at International Seminar in London
    Health

    Indian Doctor Gains Spotlight for Osteomyelitis Cure at International Seminar in London

    WebDeskBy WebDeskNovember 4, 2025No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi [India], November 4: In a landmark moment for Indian homoeopathy, Dr Vikas Singhal, a Chandigarh-based Classical Homoeopathic Physician, presented a fully cured case of chronic Osteomyelitis at the International Homoeopathic Congress 2025 held in London. The prestigious seminar, organised by the Hahnemann College of Homoeopathy (UK) at Hotel Holiday Inn, T5, Slough, brought together leading practitioners, researchers, and educators from 24 countries.

    The event was notably endorsed in writing by Charles Tankard Hahnemann, the seventh-generation descendant of Dr Samuel Hahnemann, the founder of homoeopathy. Also in attendance were Dr Shashi Mohan Sharma, Director and Principal of the Hahnemann College of Homoeopathy (UK), and Dr Lora Georgieva, a renowned Bulgarian homoeopath.

    Dr. Singhal’s presentation detailed the complete recovery of a 19-year-old male patient from Tinsukiya, Assam, suffering from post-operative chronic Osteomyelitis of the femur — a severe and persistent bone infection that had defied years of conventional medical treatment. The patient had undergone multiple surgeries and antibiotic regimens before being advised amputation as a final option.

    Seeking an alternative, the patient consulted Dr Singhal at Dr Singhal Homeo Clinic, Chandigarh, in late 2020. Over the course of three and a half years of personalised homoeopathic treatment, ending in April 2024, the patient achieved full recovery. The case was supported by both clinical and radiological evidence, confirming the regeneration of bone tissue and complete healing of the infection. The patient remained symptom-free for one year of follow-up without relapse.

    Dr Singhal’s evidence-backed presentation attracted widespread appreciation for its methodical documentation, radiological validation, and scientific rigour. Delegates from countries including the UK, USA, Romania, Bulgaria, Ghana, Nigeria, Canada, Serbia, Pakistan, Portugal, Bangladesh, Scotland, and Ireland praised the case as a model example of modern, research-oriented homoeopathy.

    During his talk, Dr Singhal emphasised the importance of systematic case reporting, peer-reviewed publications, and global collaboration to integrate classical homoeopathic practice with contemporary medical research frameworks. The recognition of Dr Singhal’s work at an international platform highlights India’s increasing contribution to evidence-based homoeopathic research. The success of this Osteomyelitis case reinforces the potential of individualised homoeopathic medicine in addressing complex, chronic, and rare medical conditions.

    The London seminar served not only as a validation of Dr Singhal’s meticulous clinical approach but also as a proud moment for India’s homoeopathic fraternity, which continues to make global strides in scientific, ethical, and research-led healing practices. The event, held on October 25, 2025, at Hotel Holiday Inn, T5, Slough, London, was organised by the Hahnemann College of Homoeopathy, UK, and attended by Dr Shashi Mohan Sharma, Dr Lora Georgieva, and international delegates from 24 countries.

    The presented case involved a 19-year-old male from Tinsukiya, Assam, diagnosed with post-surgical chronic Osteomyelitis of the femur. His treatment began in November 2020 and concluded in April 2024, followed by a one-year recurrence-free observation period. The successful recovery was documented through detailed clinical notes, imaging reports, and consistent follow-ups, setting a new benchmark for evidence-based homoeopathic case management at the global level.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

    Health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    WebDesk
    • Website

    Related Posts

    AtHomeCare™ Trials Integrated App to Streamline Post-Discharge Care, Reduce Readmissions

    October 30, 2026

    How India’s Pet Industry Can Be Enhanced with Digital Infrastructure for Information, Intelligence and Trade

    October 29, 2026

    Fredna Vet Diagnostics Uncovers Widespread Bone Tumour in Dog Through Advanced CT Imaging

    October 28, 2026

    Comments are closed.

    Recent Post
    • Lord’s Mark Industries’ Brahamastra Takes Indigenous Defence Innovation to the Global Stage
    • Sudarshan Pharma Q2 Profit Surges 86% to Rs 7.78 Crore as Margins Improve; Revenue Jumps 28%
    • Escorts Kubota to raise tractor prices post-Diwali due to rising input costs
    • Eastern India’s Next Leg Of Growth Will Be Built On District Roads
    • Thyrocare Technologies revenue reaches INR 270.8 Cr in Q2 FY27, grows 25.1% YoY
    • One Analyst, 71,000 Investors: What Made Ankit Jaiswal Build NiveshX
    • SoftTech Engineers introduces CivitTDRx, a Digital-First Approach to Transparent TDR Transactions
    • Lincoln Pharmaceuticals Reports Rs. 57.50 crore Net Profit in H1 FY27, growth of 20.52 percent Y-o-Y

    Type above and press Enter to search. Press Esc to cancel.